Close
CDMO Safety Testing 2026
Novotech

Pilgrim Introduces Management Software to Support Pharmaceutical Manufacturing

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.
- Advertisement -

Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, announced the validated release of SmartSolve® Out Of Specification (OOS) Management.

Pilgrim’s out-of-specification software drives consistent OOS investigations and offers valuable reporting capabilities to identify areas for improvement in pharmaceutical laboratory and manufacturing processes.

The purpose of Out Of Specification Management (OOS) investigations is to identify the root cause of the lab result, correct the issue, and ensure all product that reaches market is to-specification and sound for patient use and public safety. Pharmaceutical and combination product manufacturers need an effective, consistent methodology to conduct laboratory and full-scale manufacturing investigations.

Pilgrim’s Out Of Specification Management software design mirrors FDA guidance on out-of-specification lab result investigations and provides tools to reduce risk. This includes the ability to create a corrective or preventive action (CAPA) only when the risk level dictates its need.

“Through our experience working directly with clients in the pharmaceutical industry, Pilgrim understands the importance of having a solution to facilitate a consistent, effective out-of-specification process,” said Kari Miller, Pilgrim Regulatory and Product Management leader. “SmartSolve Out Of Specification Management provides our clients with the tools and resources they need to implement a compliant OOS process, and to generate the proper level or levels of investigation, objective evidence, and trending needed to maintain compliance and be audit-ready.”

Pilgrim continues to enhance its SmartSolve suite to support the quality management processes key to Life Sciences organizations. The latest Out Of Specification Management software is a key step toward meeting the specific demands of enterprises within the pharmaceutical and combination product arenas.

In addition to supporting consistent investigations and reducing risk, the out-of-specification software helps drive continuous improvement in quality and manufacturing with robust reporting for root cause analysis and identifying trends over time, including out-of-trend (OOT) results.

Out Of Specification Management is an integrated part of SmartSolve, Pilgrim’s quality management suite of solutions. Integration across the platform ensures that related quality events, including CAPAs and deviations, are addressed through the consistent application of regulatory standards. This means the out-of-specification software facilitates compliance with regulatory requirements, including FDA’s 21 CFR Parts 11, 210 and 211.

About Pilgrim Quality Solutions
Pilgrim Quality Solutions is the leader in quality compliance management software and services for Life Sciences. For more than 20 years, our solutions have automated thousands of processes across global company sites to manage the quality and compliance of life’s most important products. Our cloud-based and on-premise solutions include in-the-box best practice workflows, document and process management, dashboards, electronic signatures, audit trails, and automated validation – helping companies more easily achieve quality system compliance and pass regulatory audits. Pilgrim Quality Solutions is majority owned by Boston-based private equity firm, Riverside Partners LLC. With Pilgrim Quality Solutions as your partner, you are prepared to succeed. For more information, visit www.pilgrimquality.com

 

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

GMP Compliance in Analytical Testing and Color Control

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »